Gan & Lee Pharmaceuticals. (603087.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 40.33B |
| Enterprise Value | 38.37B |
| P/E Ratio | 39.9 |
| PEG Ratio | 1.59 |
| Price/Sales Ratio | 11 |
| Price/Book Ratio | 3.93 |
| Enterprise/Revenue | 10.45 |
| Enterprise/EBITDA | 44.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.27 |
| Operating Margin | 0.2 |
| Return On Assets | 0.09 |
| Return On Equity | 0.1 |
| Revenue | 4.04B |
| Revenue/Share | 7.09 |
| Gross Profit | 2.94B |
| EBITDA | 1.07B |
| Net Income | 1.14B |
| Diluted EPS | 1.93 |
| Total Cash | 3.96B |
| Total Cash/Share | 6.66 |
| Total Debt | 210.68M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 6.91 |
| Book Value Per Share | 19.76 |
| 52-Week Change | 2.31 |
| 52-Week High | 79.99 |
| 52-Week Low | 51.51 |
| Moving Average 50 Days | 70.19 |
| Moving Average 200 Days | 64.61 |
| Average Volume | 12.42M |
| Shares Outstanding | 597.93M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.29 |
| Payout Ratio | 0.52 |
| Last Split Factor | 7:5 |
| Last Split Date | August 20, 2020 |